2025’s Most-Read Stories for GPs

2025’s Most-Read Stories for GPs

18 Dec 2025

1. MBS Changes Take Effect

Significant changes to Medicare items for chronic disease management, vitamin B12 testing, and COVID-19 support came into effect on 1 July.
Published: 30 June

2. Semaglutide’s Benefits and Risks

A study examined GLP-1 receptor agonists (GLP-1RAs), showing reduced risk for 42 health outcomes but increased risk for 19, highlighting the broad effects of these weight-loss and diabetes medicines.
Published: 21 January

3. Telehealth Regulation Updates

From 1 November, telehealth services will need to be linked to a patient’s registered MyMedicare practice, marking an important regulatory change for GPs.
Published: 31 January

4. ADHD Prescribing Expansion

West Australian GPs may soon be able to diagnose ADHD and start treatment with stimulant medications, a move described as a “breakthrough” for patient care.
Published: 14 February

5. Diabetes Guideline Update

New clinical guidelines raised the threshold for gestational diabetes after years of debate. GPs largely support the update, which addresses concerns about over-diagnosis.
Published: 24 June

6. Proposed Vitamin B6 Restrictions

The Therapeutic Goods Administration (TGA) proposed some vitamin B6 products become pharmacist-only, following safety concerns.
Published: 30 June

7. Push for PBS Listing of Weight-Loss Drugs

The Health Minister requested advice on equitable access to obesity treatments, with GPs supporting subsidised access to weight-loss medicines.
Published: 4 July

8. Human Metapneumovirus (HMPV) Concerns

With HMPV cases rising overseas, Australian GPs were alerted to be prepared for potential cases in their practices.
Published: 9 January

9. Melatonin Sales Suspended

A major online retailer paused melatonin sales, prompting experts to call for a fresh look at how sleep problems in children are managed.
Published: 1 September

10. Mounjaro Approved for Sleep Apnoea

Sleep specialists welcomed the approval of Mounjaro as the first medicine indicated for obstructive sleep apnoea in patients with obesity.
Published: 4 June

These stories reflect the wide-ranging issues Australian GPs navigated in 2025 – from new treatments and guidelines to regulatory changes and public health alerts.

Source: newsGP, RACGP, TGA